Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Hoon Maeng

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Oncology|March 22, 2012
Implications of different CA 15-3 levels according to breast cancer subtype at initial diagnosis of recurrent or metastatic breast cancerSilvia Park, Hee Kyung Ahn, Lee Chun Park, et al.
American Journal of Hematology|June 26, 2012
The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphomaSilvia Park, Seung Hwan Moon, Lee Chun Park, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2010
The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)Jae Jin Lee, Chi Hoon Maeng, Seon Kyung Baek, et al.
The Oncologist|August 22, 2018
A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01)Keun-Wook Lee, Chi Hoon Maeng, Tae-You Kim, et al.
Acta Haematologica|December 4, 2013
Positive correlation between baseline PET or PET/CT findings and clinical parameters in multiple myeloma patientsSilvia Park, Su Jin Lee, Won Jin Chang, et al.
Scientific Reports|August 31, 2017
The Prognostic 97 Chemoresponse Gene Signature in Ovarian CancerAbel Matondo, Yong Hwa Jo, Muhammad Shahid, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2019
Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family membersShin Hye Yoo, Jihye Lee, Jung Hun Kang, et al.
BMC Cancer|December 14, 2012
Unique perception of clinical trials by Korean cancer patientsSu Jin Lee, Lee Chun Park, Jeeyun Lee, et al.
Anticancer Research|November 14, 2013
High-throughput molecular genotyping for small biopsy samples in advanced non-small cell lung cancer patientsChi Hoon Maeng, Ho Yun Lee, Young Wook Kim, et al.
Current Problems in Cancer|March 28, 2022
Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failureJoo-Hwan Park, Inkeun Park, In-Ho Kim, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Oncology|March 22, 2012
Implications of different CA 15-3 levels according to breast cancer subtype at initial diagnosis of recurrent or metastatic breast cancerSilvia Park, Hee Kyung Ahn, Lee Chun Park, et al.
American Journal of Hematology|June 26, 2012
The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphomaSilvia Park, Seung Hwan Moon, Lee Chun Park, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2010
The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)Jae Jin Lee, Chi Hoon Maeng, Seon Kyung Baek, et al.
The Oncologist|August 22, 2018
A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01)Keun-Wook Lee, Chi Hoon Maeng, Tae-You Kim, et al.
Acta Haematologica|December 4, 2013
Positive correlation between baseline PET or PET/CT findings and clinical parameters in multiple myeloma patientsSilvia Park, Su Jin Lee, Won Jin Chang, et al.
Scientific Reports|August 31, 2017
The Prognostic 97 Chemoresponse Gene Signature in Ovarian CancerAbel Matondo, Yong Hwa Jo, Muhammad Shahid, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2019
Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family membersShin Hye Yoo, Jihye Lee, Jung Hun Kang, et al.
BMC Cancer|December 14, 2012
Unique perception of clinical trials by Korean cancer patientsSu Jin Lee, Lee Chun Park, Jeeyun Lee, et al.
Anticancer Research|November 14, 2013
High-throughput molecular genotyping for small biopsy samples in advanced non-small cell lung cancer patientsChi Hoon Maeng, Ho Yun Lee, Young Wook Kim, et al.
Current Problems in Cancer|March 28, 2022
Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failureJoo-Hwan Park, Inkeun Park, In-Ho Kim, et al.
Pageof 7